Abiopharma

(90% Positive) ENVOY MEDICAL, INC. (COCH) Announces Enrollment Update for changes Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

(90% Positive) LIPOCINE INC. (LPCN) Announces Enrollment Update for track Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

(99% Neutral) KALA BIO, Inc. (KALA) Announces Business Combination

Director TRAVERSA SERGIO 🟢 acquired 1.2M shares (1 derivative) of RELMADA THERAPEUTICS, INC. (RLMD) at $4.12 ($5.0M) Transaction Date: Dec 12, 2025 | Filing ID: 121974

Shenouda Maged 🟢 acquired 839.7K shares (1 derivative) of RELMADA THERAPEUTICS, INC. (RLMD) at $4.12 ($3.4M) Transaction Date: Dec 12, 2025 | Filing ID: 121973

Ence Chuck 🟢 acquired 828.0K shares (1 derivative) of RELMADA THERAPEUTICS, INC. (RLMD) at $4.06 ($3.4M) Transaction Date: Dec 12, 2025 | Filing ID: 121972

Director Fedeli Fabiana 🟢 acquired 164.0K shares (1 derivative) of RELMADA THERAPEUTICS, INC. (RLMD) at $4.06 Transaction Date: Dec 12, 2025 | Filing ID: 121971

Director GLASSPOOL JOHN 🟢 acquired 164.0K shares (1 derivative) of RELMADA THERAPEUTICS, INC. (RLMD) at $4.06 Transaction Date: Dec 12, 2025 | Filing ID: 121969

Director Kelly Paul Edward 🟢 acquired 828.0K shares (1 derivative) of RELMADA THERAPEUTICS, INC. (RLMD) at $4.06 ($3.4M) Transaction Date: Dec 12, 2025 | Filing ID: 121968

Director CASAMENTO CHARLES J 🟢 acquired 164.0K shares (1 derivative) of RELMADA THERAPEUTICS, INC. (RLMD) at $4.06 Transaction Date: Dec 12, 2025 | Filing ID: 121967